查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
分子诊断的全球市场 - 成长，未来展望，竞争分析(2022年～2030年)
市场调查报告书
商品编码
1180682

分子诊断的全球市场 - 成长，未来展望，竞争分析(2022年～2030年)

Molecular Diagnostics Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日期: | 出版商: Acute Market Reports | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

由于患需要迅速诊断的慢性疾病的患者增加，个体化药物治疗的需求高涨，药物遗传学的出现，推进公共卫生和福利的政府配合措施等，推动全球分子诊断的市场。

本报告提供全球分子诊断市场调查，市场概要，市场分析，各产品、各技术、各用途、各地区的分析，竞争情形，及企业简介等全面性资讯。

目录

第1章 序文

  • 报告的说明
    • 报告的目的
    • 目标受众
    • 主要的产品
  • 市场区隔
  • 调查手法
    • I期 - 2次调查
    • II期 - 1次调查
    • III期 - 专家的审查
    • 前提条件
    • 所采用的方法

第2章 摘要整理

  • 市场概述:全球分子诊断市场
  • 全球分子诊断市场，各产品，2021年
  • 全球分子诊断市场，各技术，2021年
  • 全球分子诊断市场，各用途，2021年
  • 全球分子诊断市场，各地区，2021年
  • 富有魅力的投资提案，各地区，2021年

第3章 分子诊断市场:竞争分析

  • 主要的分子诊断市场供应商的市场定位
  • 分子诊断市场供应商采用的策略
  • 主要的产业策略
  • 等级分析，2021年对2030年

第4章 分子诊断市场:常量分析和市场动态

  • 简介
  • 全球分子诊断市场金额(2020年～2030年)
  • 市场动态
    • 推动市场要素
    • 阻碍市场要素
    • 主要课题
    • 主要的机会
  • 促进因素与阻碍因素的影响分析
  • See-Saw分析

第5章 分子诊断市场:各产品(2020年～2030年)

  • 市场概要
  • 成长和收益分析:2021年对2030年
  • 市场区隔
    • 试剂、套件
    • 设备
    • 服务、软体

第6章 分子诊断市场:各技术(2020年～2030年)

  • 市场概要
  • 成长和收益分析:2021年对2030年
  • 市场区隔
    • 聚合酵素链锁反应
    • 恆温核酸增幅技术
    • In Situ 杂合反应(ISH)
    • 微阵列
    • 其他

第7章 分子诊断市场:各用途(2020年～2030年)

  • 市场概要
  • 成长和收益分析:2021年对2030年
  • 市场区隔
    • 感染疾病
    • 肿瘤学
    • 次世代定序
    • DNA定序
    • 微生物学
    • 其他

第8章 北美的分子诊断市场(2020年～2030年)

  • 市场概要
  • 分子诊断市场:各产品(2020年～2030年)
  • 分子诊断市场:各技术(2020年～2030年)
  • 分子诊断市场:各用途(2020年～2030年)
  • 分子诊断市场:各地区(2020年～2030年)
    • 北美

第9章 英国、欧洲联盟的分子诊断市场(2020年～2030年)

  • 市场概要
  • 分子诊断市场:各产品(2020年～2030年)
  • 分子诊断市场:各技术(2020年～2030年)
  • 分子诊断市场:各用途(2020年～2030年)
  • 分子诊断市场:各地区(2020年～2030年)
    • 英国、欧洲联盟

第10章 亚太地区的分子诊断市场(2020年～2030年)

  • 市场概要
  • 分子诊断市场:各产品(2020年～2030年)
  • 分子诊断市场:各技术(2020年～2030年)
  • 分子诊断市场:各用途(2020年～2030年)
  • 分子诊断市场:各地区(2020年～2030年)
    • 亚太地区

第11章 南美的分子诊断市场(2020年～2030年)

  • 市场概要
  • 分子诊断市场:各产品(2020年～2030年)
  • 分子诊断市场:各技术(2020年～2030年)
  • 分子诊断市场:各用途(2020年～2030年)
  • 分子诊断市场:各地区(2020年～2030年)
    • 南美

第12章 中东、非洲的分子诊断市场(2020年～2030年)

  • 市场概要
  • 分子诊断市场:各产品(2020年～2030年)
  • 分子诊断市场:各技术(2020年～2030年)
  • 分子诊断市场:各用途(2020年～2030年)
  • 分子诊断市场:各地区(2020年～2030年)
    • 中东、非洲

第13章 企业简介

  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • Bayer AG
  • Becton Dickinson and Company
  • BioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F.Hoffman La-Roche Ltd.
  • Novartis AG
  • Qiagen N.V.
  • Siemens Healthcare
  • Sysmex Corporation
Product Code: 137593-08-22

This report on global molecular diagnostics market studies various products, applications and technologies used in the field of molecular diagnostics. Increasing number of patients suffering with chronic illnesses requiring prompt diagnosis, rising demand for personalized medication, advent of pharmacogenomics, and government initiatives in promoting public health and welfare will propel the molecular diagnostics market. The limiting factors related to this market is the complex regulatory scenario for approvals to molecular diagnostic kits which vary according to countries. Technological advancement in the design and manufacture of diagnostic kits will result into deep market penetration of molecular diagnostics solutions in the market.

For the purpose of this study, the various products studied include reagents and kits, instruments, services, and software; applications studied for the purpose of this research are segmented as infectious disease, oncology, next-generation sequencing, DNA sequencing, microbiology, and others. The molecular diagnostic technologies are further categorized as polymerase chain reaction, isothermal nucleic acid amplification technology, in situ hybridization, microarray and others.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global molecular diagnostics market. Competition assessment tools such as Porter's five forces analysis, market attractiveness assessment, and competitive landscape analysis by key players are also presented in the study. Furthermore, this report concludes with profiling of key players currently enjoying prominent position in the global molecular diagnostics market. The key players profiled in this report are Abbott Laboratories, Inc., Alere, Inc., Bayer AG, Becton Dickinson and Company, BioMerieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, F.Hoffman La-Roche Ltd., Novartis AG, Qiagen N.V., Siemens Healthcare, and Sysmex Corporation.

Diverse reagents and kits such as acetonitrile, methane, Baeyer's reagent, carbon disulfide, Brdu ELISA kit, typhoid kit, hepatitis B detection kit, etc. are available to perform clinical and molecular diagnosis of diseases. Sophisticated instruments such as high-performance liquid chromatography (HPLC), mass spectrometry, gas chromatography and nuclear magnetic resonance (NMR) are employed to identify and detect various pathogens and other biopsy parameters present in the samples obtained from patients suffering with different ailment. Software that are utilized in these instruments are undergoing rapid transition in order to meet the requirement of accurate, precise and reliable data analysis and interpretation of the disease under investigation.

In 2021, reagent and kits held the largest revenue share in the product segments due to its diverse application in hospitals, research organizations and academic institutions and high reliability and interpretation as compared to other automated tools employed for diagnosis like sonography, CT scan and MRI. Additionally, instruments is estimated to be the fastest growing segment over the forecast period 2022-2030, majorly due to factors such as technological advancement in design and manufacture, easy handling due to enhanced automation of instruments and less time taken to perform the diagnosis as compared to the conventional techniques.

Molecular diagnostics is utilized for identification of biological markers in the human genome in order to identify gene expression respective to diseases. It is very vital in the early diagnosis of life threatening diseases where effective treatment regimen is considered immediately. Emergence of infectious diseases such as from Ebola virus and Zika virus, where early disease etiology and symptoms are difficult to detect and interpret, drives the need for molecular diagnosis. Molecular diagnostics helps to decide treatment regimen in accordance to the nature of disease and patients.

Among the considered application areas, infectious diseases hold the largest market in the application segment for the base year 2021, chiefly due to factors such as rising prevalence of infectious diseases, increasing number of primary healthcare centers in both the developed and developing worlds, government initiatives and healthcare expenditure to fight fatal disease like malaria, cholera, tuberculosis, AIDS and HPV. Oncology will be the fastest growing market in the application segment throughout the forecast period 2022-2030, due to increasing number of patients suffering with cancer, rising public awareness leading to early disease diagnosis and treatment, evolved reimbursement scenario regarding disease diagnosis.

Molecular diagnostic techniques are crucial in healthcare management as they are useful in improving patient care, contribute to protect consumer health, and assistive in limiting healthcare expenditure, which is a major economic issue throughout the world. Rising public awareness and inclination towards healthy and hygienic lifestyle, outbreak of pandemic diseases and increasing number of primary healthcare centers and supportive regulatory approval for molecular diagnostic products and services are the factors that propel the growth of global molecular diagnostics market. In 2021, polymerase chain reaction (PCR) was observed to be the largest technology segment. Vitality of PCR technology in early detection of rare diseases, rising demand for personalized medication and pharmacogenomics, and assistance in establishing DNA sequence of patients which will be helpful in the prevention of several life threatening diseases are the key factors driving this segment. Microarray will be the fastest growing market in the technology segment throughout the forecast period 2022-2030, majorly due to its ability to detect different types of cancer on the basis of the patterns of gene activity in the tumor cells; increasing demand for toxicogenomics in determining antibiotics treatment due to rising prevalence of drug resistant bacterial infection. Overall, the global molecular diagnostics market is highly competitive with presence of multiple players like F.Hoffman La-Roche Ltd., Abbott Laboratories, Novartis AG, Alere, Inc., Siemens Healthcare, Bayer AG, Becton, Dickinson and Company etc. specializing in respective fields.

North America was observed as the largest market for molecular diagnostics in the base year 2021. The dominance of North America market is mainly attributed to rising number of infectious diseases requiring immediate diagnosis, increased government healthcare expenditure to promote public health and wellbeing and favorable reimbursement scenario. Europe is expected to be the second largest market due to high prevalence of cancer, technological advancement in diagnostic techniques and positive regulatory approval for molecular diagnostic products. Asia Pacific will be the fastest growing market for the forecast period 2022-2030, the factors that propel the market growth are large patient pool undergoing diagnosis for chronic diseases, infections, and cancer, rise in market competition due to presence of existing and budding manufactures involved in production of molecular diagnostic solutions, and increasing disposable income in these regions. Factors such as development of large number of primary healthcare centers in remote areas, increasing disease awareness and increasing demand for molecular diagnostics are going to fuel the rapid growth of molecular diagnostic market in Latin America and Middle East, and Africa region in the near future.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Molecular Diagnostics market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report

Micro and macro environment factors that are currently influencing the Molecular Diagnostics market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

Reagents and Kits

Instruments

Services and Software

Technology

Polymerase Chain Reaction

Isothermal Nucleic Acid Amplification Technology

Insitu Hybridization

Microarray

Others

Application

Infectious Disease

Oncology

Next Generation Sequencing

DNA Sequencing

Microbiology

Others

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of Covid-19 Segment (2020-2021; US$ Million )

Pre Covid-19 situation

Post Covid-19 situation

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Molecular Diagnostics market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Molecular Diagnostics market?

Which is the largest regional market for Molecular Diagnostics market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Molecular Diagnostics market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Molecular Diagnostics market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Molecular Diagnostics Market
  • 2.2. Global Molecular Diagnostics Market, By Product, 2021 (US$ Million)
  • 2.3. Global Molecular Diagnostics Market, By Technology, 2021 (US$ Million)
  • 2.4. Global Molecular Diagnostics Market, By Application, 2021 (US$ Million)
  • 2.5. Global Molecular Diagnostics Market, By Geography, 2021 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2021

3. Molecular Diagnostics Market: Competitive Analysis

  • 3.1. Market Positioning of Key Molecular Diagnostics Market Vendors
  • 3.2. Strategies Adopted by Molecular Diagnostics Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Molecular Diagnostics Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Molecular Diagnostics Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Reagents and Kits
    • 5.3.2. Instruments
    • 5.3.3. Services and Software

6. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 6.3. Market Segmentation
    • 6.3.1. Polymerase Chain Reaction
    • 6.3.2. Isothermal Nucleic Acid Amplification Technology
    • 6.3.3. Insitu Hybridization
    • 6.3.4. Microarray
    • 6.3.5. Others

7. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 7.3. Market Segmentation
    • 7.3.1. Infectious Disease
    • 7.3.2. Oncology
    • 7.3.3. Next Generation Sequencing
    • 7.3.4. DNA Sequencing
    • 7.3.5. Microbiology
    • 7.3.6. Others

8. North America Molecular Diagnostics Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
  • 8.3. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
  • 8.4. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)
  • 8.5.Molecular Diagnostics Market: By Region, 2020-2030, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
        • 8.5.1.1.1. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
        • 8.5.1.1.1. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
        • 8.5.1.2.1. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
        • 8.5.1.2.1. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
        • 8.5.1.3.1. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
        • 8.5.1.3.1. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)

9. UK and European Union Molecular Diagnostics Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
  • 9.3. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
  • 9.4. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)
  • 9.5.Molecular Diagnostics Market: By Region, 2020-2030, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
        • 9.5.1.1.1. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
        • 9.5.1.1.1. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
        • 9.5.1.2.1. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
        • 9.5.1.2.1. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
        • 9.5.1.3.1. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
        • 9.5.1.3.1. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
        • 9.5.1.4.1. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
        • 9.5.1.4.1. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
        • 9.5.1.5.1. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
        • 9.5.1.5.1. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
        • 9.5.1.6.1. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
        • 9.5.1.6.1. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)

10. Asia Pacific Molecular Diagnostics Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
  • 10.3. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
  • 10.4. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)
  • 10.5.Molecular Diagnostics Market: By Region, 2020-2030, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
        • 10.5.1.1.1. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
        • 10.5.1.1.1. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
        • 10.5.1.2.1. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
        • 10.5.1.2.1. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
        • 10.5.1.3.1. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
        • 10.5.1.3.1. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
        • 10.5.1.4.1. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
        • 10.5.1.4.1. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
        • 10.5.1.5.1. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
        • 10.5.1.5.1. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
        • 10.5.1.6.1. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
        • 10.5.1.6.1. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)

11. Latin America Molecular Diagnostics Market, 2020-2030, USD (Million)

  • 11.1. Market Overview
  • 11.2. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
  • 11.3. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
  • 11.4. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)
  • 11.5.Molecular Diagnostics Market: By Region, 2020-2030, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
        • 11.5.1.1.1. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
        • 11.5.1.1.1. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
        • 11.5.1.2.1. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
        • 11.5.1.2.1. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
        • 11.5.1.3.1. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
        • 11.5.1.3.1. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)

12. Middle East and Africa Molecular Diagnostics Market, 2020-2030, USD (Million)

  • 12.1. Market Overview
  • 12.2. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
  • 12.3. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
  • 12.4. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)
  • 12.5.Molecular Diagnostics Market: By Region, 2020-2030, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
        • 12.5.1.1.1. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
        • 12.5.1.1.1. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
        • 12.5.1.2.1. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
        • 12.5.1.2.1. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Molecular Diagnostics Market: By Product, 2020-2030, USD (Million)
        • 12.5.1.3.1. Molecular Diagnostics Market: By Technology, 2020-2030, USD (Million)
        • 12.5.1.3.1. Molecular Diagnostics Market: By Application, 2020-2030, USD (Million)

13. Company Profile

  • 13.1. Abbott Laboratories, Inc.
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. Alere, Inc.
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. Bayer AG
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Becton Dickinson and Company
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. BioMerieux SA
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Bio-Rad Laboratories, Inc.
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. Danaher Corporation
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. F.Hoffman La-Roche Ltd.
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. Novartis AG
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. Qiagen N.V.
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives
  • 13.11. Siemens Healthcare
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Portfolio
    • 13.11.4. Strategic Initiatives
  • 13.12. Sysmex Corporation
    • 13.12.1. Company Overview
    • 13.12.2. Financial Performance
    • 13.12.3. Product Portfolio
    • 13.12.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 2 Global Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 3 Global Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 4 North America Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 5 North America Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 6 North America Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 7 U.S. Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 8 U.S. Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 9 U.S. Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 10 Canada Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 11 Canada Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 12 Canada Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 13 Rest of North America Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 14 Rest of North America Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 15 Rest of North America Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 16 UK and European Union Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 17 UK and European Union Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 18 UK and European Union Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 19 UK Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 20 UK Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 21 UK Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 22 Germany Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 23 Germany Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 24 Germany Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 25 Spain Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 26 Spain Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 27 Spain Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 28 Italy Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 29 Italy Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 30 Italy Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 31 France Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 32 France Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 33 France Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 34 Rest of Europe Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 35 Rest of Europe Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 36 Rest of Europe Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 37 Asia Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 38 Asia Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 39 Asia Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 40 China Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 41 China Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 42 China Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 43 Japan Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 44 Japan Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 45 Japan Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 46 India Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 47 India Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 48 India Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 49 Australia Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 50 Australia Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 51 Australia Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 52 South Korea Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 53 South Korea Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 54 South Korea Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 55 Latin America Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 56 Latin America Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 57 Latin America Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 58 Brazil Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 59 Brazil Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 60 Brazil Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 61 Mexico Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 62 Mexico Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 63 Mexico Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 64 Rest of Latin America Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 65 Rest of Latin America Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 66 Rest of Latin America Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 67 Middle East and Africa Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 68 Middle East and Africa Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 69 Middle East and Africa Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 70 GCC Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 71 GCC Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 72 GCC Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 73 Africa Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 74 Africa Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 75 Africa Molecular Diagnostics Market By Application, 2020-2030, USD (Million)
  • TABLE 76 Rest of Middle East and Africa Molecular Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 77 Rest of Middle East and Africa Molecular Diagnostics Market By Technology, 2020-2030, USD (Million)
  • TABLE 78 Rest of Middle East and Africa Molecular Diagnostics Market By Application, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Molecular Diagnostics Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Molecular Diagnostics Market: Quality Assurance
  • FIG. 5 Global Molecular Diagnostics Market, By Product, 2021
  • FIG. 6 Global Molecular Diagnostics Market, By Technology, 2021
  • FIG. 7 Global Molecular Diagnostics Market, By Application, 2021
  • FIG. 8 Global Molecular Diagnostics Market, By Geography, 2021
  • FIG. 9 Market Geographical Opportunity Matrix - Global Molecular Diagnostics Market, 2021
  • FIG. 10 Market Positioning of Key Molecular Diagnostics Market Players, 2021
  • FIG. 11 Global Molecular Diagnostics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 12 Global Molecular Diagnostics Market, By Product, 2021 Vs 2030, %
  • FIG. 13 Global Molecular Diagnostics Market, By Technology, 2021 Vs 2030, %
  • FIG. 14 Global Molecular Diagnostics Market, By Application, 2021 Vs 2030, %
  • FIG. 15 U.S. Molecular Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 16 Canada Molecular Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 17 Rest of North America Molecular Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 18 UK Molecular Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 19 Germany Molecular Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 20 Spain Molecular Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 21 Italy Molecular Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 22 France Molecular Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 23 Rest of Europe Molecular Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 24 China Molecular Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 25 Japan Molecular Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 26 India Molecular Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 27 Australia Molecular Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 28 South Korea Molecular Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 29 Rest of Asia Molecular Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 30 Brazil Molecular Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 31 Mexico Molecular Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 32 Rest of Latin America Molecular Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 33 GCC Molecular Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 34 Africa Molecular Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 35 Rest of Middle East and Africa Molecular Diagnostics Market (US$ Million), 2020 - 2030